Anti-Bullous Pemphigoid Antibodies in Patients with Neurological Disease

Overview

  • Study type

    Observational
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 15-005985
    Sponsor Protocol Number: 15-005985

About this study

The purpose of this study is to learn more about Lewy Body disease and a skin condition called Bullous Pemphigoid.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • Blood sample (serum) from patients with Lewy Body Dementia will be done prospectively in collaboration with our co-investigators in the Department of Neurology

 

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Carilyn Wieland, M.D.

Open for enrollment

Contact information:

Carilyn Wieland M.D.

(507)284-4672